Table 5.
BUT, SLC-90R, and HAM-A frequencies.
BUT | SCL-90 | HAM-A | ||||||
---|---|---|---|---|---|---|---|---|
Healthy | Dysmorphic symptoms | Healthy | Depressive symptoms | Healthy | Anxiety symptoms | |||
A carrier | Total population | T0 | 54.55% | 45.45% | 68.18% | 31.82% | 56.76% | 43.24% |
T1 | 61.54% | 38.46% | 66.67% | 33.33% | 70.97% | 29.03% | ||
Δ% | -6.99% | 1.52% | -14.21% | |||||
PCG | T0 | 100.00% | 0.00% | 100.00% | 0.00% | 37.50% | 62.50% | |
T1 | 100.00% | 0.00% | 100.00% | 0.00% | 50.00% | 50.00% | ||
Δ% | 0.00% | 0.00% | -12.50% | |||||
POSG | T0 | 47.37% | 52.63% | 63.16% | 36.84% | 62.07% | 37.93% | |
T1 | 58.33% | 41.67% | 63.64% | 36.36% | 78.26% | 21.74% | ||
Δ% | -10.96% | -0.48% | -16.19% | |||||
| ||||||||
Noncarrier | Total population | T0 | 75.00% | 25.00% | 85.00% | 15.00% | 88.57% | 11.43% |
T1 | 88.89% | 11.11% | 87.50% | 12.50% | 93.10% | 6.90% | ||
Δ% | -13.89% | -2.50% | -4.53% | |||||
PCG | T0 | 100.00% | 0.00% | 100.00% | 0.00% | 100.00% | 0.00% | |
T1 | 100.00% | 0.00% | 100.00% | 0.00% | 100.00% | 0.00% | ||
Δ% | 0.00% | 0.00% | 0.00% | |||||
POSG | T0 | 70.59% | 29.41% | 82.35% | 17.65% | 86.21% | 13.79% | |
T1 | 83.33% | 16.67% | 80.00% | 20.00% | 91.30% | 8.70% | ||
Δ% | -12.75% | 2.35% | -5.10% | |||||
| ||||||||
Total | Total population | T0 | 64.29% | 35.71% | 76.19% | 23.81% | 72.22% | 27.78% |
T1 | 64.29% | 35.71% | 76.19% | 23.81% | 81.67% | 18.33% | ||
Δ% | 0.00% | 0.00% | -9.44% | |||||
PCG | T0 | 100.00% | 0.00% | 100.00% | 0.00% | 64.29% | 35.71% | |
T1 | 100.00% | 0.00% | 100.00% | 0.00% | 71.43% | 28.57% | ||
Δ% | 0.00% | 0.00% | -7.14% | |||||
POSG | T0 | 58.33% | 41.67% | 72.22% | 27.78% | 74.14% | 25.86% | |
T1 | 66.67% | 33.33% | 68.75% | 31.25% | 84.78% | 15.22% | ||
Δ% | -8.33% | 3.47% | -10.64% |
Frequencies for positive/negative classification on depression, dysmorphic, and anxiety symptoms evaluated with Body Uneasiness Test (BUT), Symptom Checklist-Revised (SCL90R), and Hamilton Anxiety Rating Scale (HAM-A). Results are expressed as percentage. POSG: psychobiotic oral suspension group; PCG: placebo control group.